Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

Download PDF Copy

Nov 6 2009

The Alliance Québécoise du Psoriasis (Quebec psoriasis alliance) would like to give its members and other psoriasis sufferers information concerning the massive H1N1 vaccination campaign.

All patients who are receiving systemic treatment (methotrexate, cyclosporine, biotherapy) MUST get the flu vaccine as soon as possible. Those taking acitetrin can follow the regular vaccination schedule. It is recommended that anyone receiving biotherapy receive the vaccination. Systemic treatments affect the immune system, which is why it is important to be vaccinated for your protection.

If patients receiving systemic treatment contract the (A)H1N1 virus, they MUST stop treatment until they recover. Be sure to receive a proper diagnosis from a health care specialist. Please note that the information in this press release does not replace the advice of your qualified health care professional.

Source: ALLIANCE QUEBECOISE DU PSORIASIS

Source: PSORIASIS QUEBEC.ORG

Source:

FLU VIRUS UPDATE

Posted in: Disease/Infection News | Healthcare News

Comments (0)

Download PDF Copy

Suggested Reading

New study identifies wedelolactone as a potent topical treatment for psoriasis

Study reveals potential new strategy to prevent or slow progression of Type 1 diabetes

Understanding immune drift in biologic therapy for inflammatory skin diseases

What makes H5N1 a pandemic risk and how can we stop it?

Abdominal fat emerges as independent risk factor for psoriasis in women

Therapeutic potential of houttuynia cordata polysaccharide in H1N1 and MRSA-induced acute pneumonia

UCLA researchers discover new way to prevent immunotherapy-induced type 1 diabetes

WHO expands essential medicines lists with new cancer and diabetes treatments

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.